Cardiovascular Benefits of Salvia miltiorrhiza (Danshen) Supplementation: Bioactive Constituents, Mechanisms, Clinical Evidence and Implications for Nutritional Care
Food Science & Nutrition · 2026-05 · 14 (5)
DOI: 10.1002/fsn3.71755 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Food Science & Nutrition, online erschienen am 26.04.2026. Verfasst von Akash Vikal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sahu Onkar Saran School of Pharmacy, Faculty of Pharmacy IFTM University Moradabad India. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, creating interest in adjunctive strategies that complement standard care. Salvia miltiorrhiza (Danshen), a traditional Chinese medicinal herb rich in tanshinones and salvianolic acids, has been investigated for multi‐target cardiovascular effects. This narrative review summarizes key phytochemical classes, preclinical mechanisms, human clinical findings, and formulation approaches aimed at improving bioavailability. Preclinical studies consistently report antioxidative, anti‐inflammatory, vasodilatory, antithrombotic, and anti‐fibrotic activities, involving pathways such as endothelial nitric oxide signaling and modulation of NF‐κB/MAPK‐related inflammation. Clinical studies have reported potential benefits in conditions such as coronary artery disease and myocardial ischemia; however, the overall evidence is limited by heterogeneity in preparations and dosing, variable product composition, small sample sizes, and a shortage of rigorously designed trials. Practical translation is further constrained by poor solubility and rapid metabolism of key constituents, though delivery platforms (e.g., liposomes, nanoparticles, and self‐microemulsifying systems) may enhance exposure in experimental settings. Overall, Danshen remains a plausible adjunct candidate, but standardization and high‐quality randomized clinical trials are needed to establish efficacy, safety, and interaction risk with conventional cardiovascular therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sahu Onkar Saran School of Pharmacy, Faculty of Pharmacy IFTM University Moradabad India.
- Department of Pharmaceutics ISF College of Pharmacy Moga Punjab India.
- Department of Pharmaceutics ISF College of Pharmacy Moga India.
- Aromatic Plant Research Center Suite Lehi USA.
- Department of Chemistry University of Alabama in Huntsville Huntsville Alabama USA.
- Universidad Espíritu Santo Samborondón Ecuador.
ORCID-Profile: Preeti Patel, William N Setzer, Javad Sharifi-Rad, Daniela Calina
Zitieren
APA
Vikal, A., Maurya, R., Patel, P., Kurmi, B. D., Setzer, W. N., Sharifi-Rad, J., & Calina, D. (2026). Cardiovascular Benefits of Salvia miltiorrhiza (Danshen) Supplementation: Bioactive Constituents, Mechanisms, Clinical Evidence and Implications for Nutritional Care. Food Science & Nutrition, 14(5). https://doi.org/10.1002/fsn3.71755
Vancouver
Vikal A, Maurya R, Patel P, Kurmi BD, Setzer WN, Sharifi-Rad J, et al. Cardiovascular Benefits of Salvia miltiorrhiza (Danshen) Supplementation: Bioactive Constituents, Mechanisms, Clinical Evidence and Implications for Nutritional Care. Food Science & Nutrition. 2026;14(5). doi:10.1002/fsn3.71755
BibTeX
@article{Vikal2026,
author = {Vikal, Akash and Maurya, Rashmi and Patel, Preeti and Kurmi, Balak Das and Setzer, William N and Sharifi-Rad, Javad and Calina, Daniela},
title = {Cardiovascular Benefits of Salvia miltiorrhiza (Danshen) Supplementation: Bioactive Constituents, Mechanisms, Clinical Evidence and Implications for Nutritional Care},
journal = {Food Science & Nutrition},
year = {2026},
volume = {14},
number = {5},
doi = {10.1002/fsn3.71755}
}
EUVIMED